- Add four quality measures:
- Q487: Screening for Social Drivers of Health
- Q493: Adult Immunization Status
- TBD: Gains in Patient Activation Measure (PAM) Scores at 12 Months
- UREQA10: Ankylosing Spondylitis: Controlled Disease Or Improved Disease Function
- Remove Q111: Pneumococcal Vaccination Status for Older Adults in favor of adding Q493: Adult Immunization Status
- Add four improvement activities:
- IA_BE_6: Regularly Assess Patient Experience of Care and Follow Up on Findings
- IA_BE_24: Financial Navigation Program
- IA_BE_25: Drug Cost Transparency
- IA_MVP: Practice-Wide Quality Improvement in MIPS Value Pathways
Targeted Review
The CMS proposes:
- To open the targeted review submission period upon release of MIPS final scores and to keep it open for 30 days after MIPS payment adjustments are released. This would still maintain an approximately 60-day period for requesting a targeted review: about 30 days before and 30 days after payment adjustments are released.
What Does this Mean for Your Practice?
Whether and how much your practice will be impacted depends on several factors. Consider:
- Does your practice plan to report through Traditional MIPS, the Advancing Rheumatology Patient Care MVP or both?
- Will you report as a group, subgroup or individual?
- What is your practice’s eligibility?
- Does your practice have additional reporting factors, such as special status or hardship exceptions?
Practices are encouraged to contact RISE staff at [email protected] with any questions regarding how they will be affected by these proposed policies.
The ACR will comment on the proposed rule on behalf of the specialty. Members may comment to the CMS directly by 5:00 p.m. EDT on Sept. 11, 2023. The proposed changes are not finalized until the the CMS announces the final rule, which is expected around November 2023. At that time, the ACR will review and evaluate the final rule and provide more information.
Additional Resources
These are key takeaways from the proposed rule; this is not a comprehensive list of all proposed changes. Additional information is available here:
- 2024 QPP Proposed Rule
- 2024 QPP Proposed Rule Fact Sheet & Policy Comparison Table
- 2024 Proposed and Modified MVPs Guide
Questions?
Contact the Quality Payment Program at 1-866-288-8292 or [email protected].
The ACR RISE registry staff are also available to assist you with questions related to reporting for MIPS. Contact the RISE team at 404-633-3777 or [email protected].
